Evidence map›Paper›PMID 32188750›Full record

ArticlemSphere2020

Multiple Bactericidal Mechanisms of the Zinc Ionophore PBT2.

Nichaela Harbison-Price, Scott A Ferguson, Adam Heikal, George Taiaroa, Kiel Hards, Yoshio Nakatani, David Rennison, Margaret A Brimble, Ibrahim M El-Deeb, Lisa Bohlmann and 4 more

Open access · goldAbstract read
In one paragraph

Article in mSphere, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 35 citations in OpenAlex.

  1. SWATH-MS proteomic data set ofMicrobiology resource announcements · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Redox-Controlled Chalcogen Bonding as a Modulator of ZnClJournal of the American Chemical Society · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Decoding the Implications of Zinc in the Development and Therapy of Leukemia.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Review
  10. Review
  11. TheFrontiers in cellular and infection microbiology · 2025
    Article
  12. Review
  13. Review
  14. The promise of copper ionophores as antimicrobials.Current opinion in microbiology · 2023
    Review
  15. Article
  16. Chelator PBT2 Forms a Ternary CuInternational journal of molecular sciences · 2023
    Article
  17. The Molecular Basis for Zinc Bioavailability.International journal of molecular sciences · 2023
    Review
  18. Rational Design of Silicon-Based Zinc Ionophores.Angewandte Chemie (International ed. in English) · 2022
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 2 countries.

Nichaela Harbison-PriceDepartment of Microbiology and Immunology, University of Otago, Dunedin, New Zealand.
Scott A FergusonDepartment of Microbiology and Immunology, University of Otago, Dunedin, New Zealand.ORCID 0000-0001-7937-8273
Adam HeikalDepartment of Microbiology and Immunology, University of Otago, Dunedin, New Zealand.
George TaiaroaDepartment of Microbiology and Immunology, University of Otago, Dunedin, New Zealand.
Kiel HardsDepartment of Microbiology and Immunology, University of Otago, Dunedin, New Zealand.
Yoshio NakataniDepartment of Microbiology and Immunology, University of Otago, Dunedin, New Zealand.
David RennisonSchool of Chemical Sciences, University of Auckland, Auckland, New Zealand.
Margaret A BrimbleSchool of Chemical Sciences, University of Auckland, Auckland, New Zealand.
Ibrahim M El-DeebInstitute for Glycomics, Griffith University, Queensland, Australia.
Lisa BohlmannSchool of Chemistry and Molecular Biosciences, Australian Infectious Diseases Research Centre, The University of Queensland, Queensland, Australia.
Christopher A McDevittDepartment of Microbiology and Immunology, The Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, Victoria, Australia.ORCID 0000-0003-1596-4841
Mark von ItzsteinInstitute for Glycomics, Griffith University, Queensland, Australia.
Mark J WalkerSchool of Chemistry and Molecular Biosciences, Australian Infectious Diseases Research Centre, The University of Queensland, Queensland, Australia.ORCID 0000-0001-7423-2769
Gregory M CookDepartment of Microbiology and Immunology, University of Otago, Dunedin, New Zealand gregory.cook@otago.ac.nz.
University of Otago · NZGriffith University · AUThe University of Queensland · AUUniversity of Auckland · NZThe University of Melbourne · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Globally, more antimicrobials are used in food-producing animals than in humans, and the extensive use of medically important human antimicrobials poses a significant public health threat in the face of rising antimicrobial resistance (AMR). The development of novel ionophores, a class of antimicrobials used exclusively in animals, holds promise as a strategy to replace or reduce essential human antimicrobials in veterinary practice. PBT2 is a zinc ionophore with recently demonstrated antibacterial activity against several Gram-positive pathogens, although the underlying mechanism of action is unknown. Here, we investigated the bactericidal mechanism of PBT2 in the bovine mastitis-causing pathogen,

Indexed as

AnimalsAnti-Bacterial AgentsCattleClioquinolFemaleIonophoresMastitis, BovineOxidative StressReactive Oxygen SpeciesStreptococcusSuperoxide DismutaseZincAnti-Bacterial AgentsClioquinolIonophoresPBT2 compoundReactive Oxygen SpeciesSuperoxide DismutaseZincantimicrobial resistanceionophoremanganesemetal ion homeostasisoxidative stressPBT2zinc

Identifiers

PMID32188750
PMCPMC7082140
OpenAlexW3011761546

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.